← Back to Search

Behavioural Intervention

TENS Active Treatment for Overweight

N/A
Waitlist Available
Research Sponsored by Elira, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months

Summary

This trial tests if the Elira System, which uses gentle electrical signals to help control appetite, combined with a moderate exercise and diet program, can help overweight and mildly obese people manage their weight better.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
A difference in Percent Total Body Weight Loss (%TBWL)
A responder rate of at least 35% in the active treatment
Secondary study objectives
Changes in BMI
Changes in appetite as measured by Appetite Visual Analogue Scale (VAS)
Changes in eating behaviors as measured by TFEQ scores
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TENS Active TreatmentExperimental Treatment1 Intervention
Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Management (The Elira System)
Group II: Sham Control DevicePlacebo Group1 Intervention
Sham TENS unit that provides no actual therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TENS Active Treatment
2022
N/A
~400

Find a Location

Who is running the clinical trial?

Elira, Inc.Lead Sponsor

Media Library

Elira System (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05675384 — N/A
Overweight Research Study Groups: Sham Control Device, TENS Active Treatment
Overweight Clinical Trial 2023: Elira System Highlights & Side Effects. Trial Name: NCT05675384 — N/A
Elira System (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05675384 — N/A
~118 spots leftby Dec 2025